Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesAmortization of Deferred ChargesCash from Financing ActivitiesCash from Financing ActivitiesCash from OperationsCash from OperationsChange in Account PayablesChange in Account PayablesChange in Accured ExpensesChange in Accured ExpensesChange in CashFree Cash FlowFree Cash FlowGains from Investment SecuritiesGains from Investment SecuritiesLong-Term Debt RepaymentsNet Cash FlowNet Cash FlowNet IncomeNon-cash ItemsNon-cash ItemsOther Working Capital ChangesOther Working Capital ChangesOther financing activitiesOther financing activitiesShare-based CompensationShare-based CompensationShares Issued
Growth Metrics
Income Statement
Others
EBIATLong-Term Debt RepaymentsMachine, Furnitures, Fixtures & OtherOther Gross PP&E AdjustmentsOther Gross PP&E AdjustmentsShares IssuedShares OutstandingShares Outstanding
Ratios

Adaptin Bio (APTN) Long-Term Debt Repayments (2025)

Adaptin Bio recorded quarterly Long-Term Debt Repayments of $275000.0 in Q1 2025.

Adaptin Bio's Long-Term Debt Repayments history runs 1 years deep, the most recent figure standing at $275000.0 for Q1 2025.

  • In Q1 2025, Long-Term Debt Repayments changed N/A year-over-year to $275000.0; the TTM figure through Dec 2025 stood at $275000.0 (changed N/A YoY), while the FY2025 annual figure was $275000.0, changed N/A from the prior year.
  • Long-Term Debt Repayments came in at $275000.0 for Q1 2025 at Adaptin Bio.
  • In the past five years, Long-Term Debt Repayments ranged from a high of $275000.0 in Q1 2025 to a low of $275000.0 in Q1 2025.

Historic Data

Download Data 🔒
DateValue
Mar 31, 2025 275,000.00
Mar 31, 2025 275,000.00